The U.S. Food and Drug Administration may come up with plans to end the ongoing coronavirus pandemic soon.
Pharmaceutical company Pfizer will be expected to submit its request on Friday for emergency use authorization of its COVID-19 vaccine.
The company, in association with its German partner BioNTech claimed that their vaccine is 95% effective and protects many older, high-risk patients from dying.
The company is planning to produce 50 million vaccine doses in 2020 and up to 1.3 billion doses by the end of 2021 across the globe.
FDA may take up to four weeks to approve their request.
If this request is approved, the company plans to distribute the 2-dose vaccine to individual countries. However, most agree that first responders and other at-risk healthcare workers should get the first injections. Medical experts say it could be several more months before the vaccine is widely available to the public.
Not only distributing vaccine but storing it is a challenge for hospitals too. According to Pfizer, the drug must be kept in freezing, sub-zero temperatures.
The company designed temperature-controlled containers that will use dry ice. Each box also has a GPS device to track the location and temperature of each shipment.